Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor biomarkers in melanoma.
Ugurel S, Utikal J, Becker JC. Ugurel S, et al. Cancer Control. 2009 Jul;16(3):219-24. doi: 10.1177/107327480901600303. Cancer Control. 2009. PMID: 19556961 Free article. Review.
Immunogenicity of constitutively active V599EBRaf.
Andersen MH, Fensterle J, Ugurel S, Reker S, Houben R, Guldberg P, Berger TG, Schadendorf D, Trefzer U, Bröcker EB, Straten Pt, Rapp UR, Becker JC. Andersen MH, et al. Among authors: ugurel s. Cancer Res. 2004 Aug 1;64(15):5456-60. doi: 10.1158/0008-5472.CAN-04-0937. Cancer Res. 2004. PMID: 15289355
[Serum markers for melanoma].
Ugurel S. Ugurel S. Hautarzt. 2005 Feb;56(2):173-84; 185-6. doi: 10.1007/s00105-004-0893-2. Hautarzt. 2005. PMID: 15657726 German.
Lack of clinical efficacy of imatinib in metastatic melanoma.
Ugurel S, Hildenbrand R, Zimpfer A, La Rosée P, Paschka P, Sucker A, Keikavoussi P, Becker JC, Rittgen W, Hochhaus A, Schadendorf D. Ugurel S, et al. Br J Cancer. 2005 Apr 25;92(8):1398-405. doi: 10.1038/sj.bjc.6602529. Br J Cancer. 2005. PMID: 15846297 Free PMC article. Clinical Trial.
[90-year-old male with a hyperkeratotic lichenoid skin eruption].
Bauer U, Ugurel S, Utikal J, Schadendorf D, Goerdt S. Bauer U, et al. Among authors: ugurel s. J Dtsch Dermatol Ges. 2005 Feb;3(2):137-9. doi: 10.1111/j.1610-0378.2005.04082.x. J Dtsch Dermatol Ges. 2005. PMID: 16351017 German. No abstract available.
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.
Schadendorf D, Ugurel S, Schuler-Thurner B, Nestle FO, Enk A, Bröcker EB, Grabbe S, Rittgen W, Edler L, Sucker A, Zimpfer-Rechner C, Berger T, Kamarashev J, Burg G, Jonuleit H, Tüttenberg A, Becker JC, Keikavoussi P, Kämpgen E, Schuler G; DC study group of the DeCOG. Schadendorf D, et al. Among authors: ugurel s. Ann Oncol. 2006 Apr;17(4):563-70. doi: 10.1093/annonc/mdj138. Epub 2006 Jan 17. Ann Oncol. 2006. PMID: 16418308 Free article. Clinical Trial.
317 results